{"schema_version":"1","generated_at":"2026-11-21T03:26:26.545Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/arash-mostaghimi","json_url":"https://www.findmykol.com/kol/arash-mostaghimi/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"arash-mostaghimi","name":"Arash Mostaghimi","credential":"MD, MPH","title":"Vice Chair of Clinical Trials and Innovation","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"Brigham and Women's Hospital","institution_url":"https://www.findmykol.com/institution/brigham-and-women-s-hospital","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Arash Mostaghimi is Vice Chair of Clinical Trials and Innovation at Brigham and Women's Hospital. OpenAlex indexes 551 publications with 7,809 citations (h-index 45); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the FindMyKOL directory.","overview":{"text":"Arash Mostaghimi, MD, MPA, MPH, is Vice Chair of Clinical Trials and Innovation at Brigham and Women's Hospital. The public record shows 551 publications with 7,809 citations (h-index 45), centered on Dermatology and Skin Diseases, Hair Growth and Disorders, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 13 companies.","bullets":["Most recent indexed publication: 2026 · Journal of the European Academy of Dermatology and Venereology","Top research focus: Dermatology and Skin Diseases","1 registered trials on ClinicalTrials.gov","Open Payments reporting from 13 companies"],"generated_at":"2026-11-20"},"focus":{"indications":[{"label":"Alopecia","therapeutic_area":"Dermatology","trials":1,"topics":0,"strength":3},{"label":"Alopecia Areata","therapeutic_area":"Dermatology","trials":1,"topics":0,"strength":3},{"label":"Acne / Hidradenitis","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Asthma","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Atopic Dermatitis / Eczema","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Atrial Fibrillation","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Bipolar Disorder","therapeutic_area":"Psychiatry","trials":0,"topics":0,"strength":1},{"label":"Cushing's Syndrome","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Dyslipidemia / Lipid Disorders","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"IBD (Crohn's / UC)","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lupus (SLE)","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"MDS / MPN","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Obesity","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Osteoporosis","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Psoriasis (Derm)","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Psoriasis / Psoriatic Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Rheumatoid Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Sepsis / Serious Bacterial","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Ankylosing Spondylitis / SpA","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Substance Use Disorders","therapeutic_area":"Psychiatry","trials":0,"topics":0,"strength":1}],"research_topics":["Dermatology and Skin Diseases","Hair Growth and Disorders","Psoriasis: Treatment and Pathogenesis","melanin and skin pigmentation","Autoimmune and Inflammatory Disorders"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Spevigo","generic":"Spesolimab","trials":0,"payments":31,"publications":2,"mentions":33},{"name":"Olumiant","generic":"Baricitinib","trials":0,"payments":4,"publications":3,"mentions":7},{"name":"Litfulo","generic":"Ritlecitinib","trials":0,"payments":5,"publications":1,"mentions":6}]},"works_with":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Eli Lilly and Company","trials":1,"payments":16,"mentions":17},{"name":"Abbvie Inc.","trials":0,"payments":50,"mentions":50},{"name":"Sun Pharmaceutical Industries Inc.","trials":0,"payments":47,"mentions":47}]}},"scholarship":{"works_count":551,"cited_by_count":7809,"h_index":45,"i10_index":159,"pubmed_count":43,"latest_activity_year":2026,"citation_standing":{"top_percent":10,"cohort":"Dermatology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07533006","title":"A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Eli Lilly and Company","source_url":"https://clinicaltrials.gov/study/NCT07533006","trial_url":"https://www.findmykol.com/trial/NCT07533006"}],"source":"trials"},"payments":{"company_count":13,"program_years":{"first":2021,"last":2025},"rows_total":32,"shown":3,"withheld":29,"rows":[{"payer":"SUN PHARMACEUTICAL INDUSTRIES INC.","program_year":2025,"amount_usd":52743.84,"payment_count":35},{"payer":"Boehringer Ingelheim International GmbH","program_year":2025,"amount_usd":45377.07,"payment_count":7},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":18189.2,"payment_count":20}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":6,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":37.4,"classes_total":4,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":22.6,"drugs":[{"name":"Ketoconazole","share_pct":70.9},{"name":"Fluconazole","share_pct":29.1}],"max_beneficiaries":null},{"class":"Tetracycline-class Drug","setting":"prescribed","share_pct":6,"drugs":[{"name":"Doxycycline Monohydrate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":17.1,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":12.9,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":100}],"max_beneficiaries":28},{"class":"Interleukin-4 Receptor alpha Antagonist","setting":"prescribed","share_pct":4.3,"drugs":[{"name":"Dupixent Pen","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":16.3,"classes_total":4,"classes":[{"class":"TNF inhibitor","setting":"prescribed","share_pct":6.3,"drugs":[{"name":"Humira Pen","share_pct":100}],"max_beneficiaries":null},{"class":"JAK inhibitor","setting":"prescribed","share_pct":3.4,"drugs":[{"name":"Olumiant","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":93.7,"facility_pct":6.3},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":67,"years":{"first":2019,"last":2026},"societies":["AAD","ASCO","ISPOR","SID"],"shown":3,"withheld":64,"rows":[{"title":"P46 PSYCHOMETRIC PERFORMANCE OF EQ-5D-5L INDEX IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA: EVIDENCE FROM PHASE III TRIAL DATA","society":"ISPOR","meeting":"ISPOR","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.jval.2026.03.072","source_url":"https://doi.org/10.1016/j.jval.2026.03.072","status":"verified"},{"title":"PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA","society":"ISPOR","meeting":"ISPOR","year":2026,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.jval.2026.03.1881","source_url":"https://doi.org/10.1016/j.jval.2026.03.1881","status":"verified"},{"title":"PCR30 PSYCHOMETRIC EVALUATION OF SKINDEX-16 AA, THE ALOPECIA AREATA SYMPTOM IMPACT SCALE (AASIS), AND THE SCALP HAIR ASSESSMENT PATIENT-REPORTED OUTCOME (PRO) IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA","society":"ISPOR","meeting":"ISPOR","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.jval.2026.03.1803","source_url":"https://doi.org/10.1016/j.jval.2026.03.1803","status":"verified"}],"source":"congress"},"publications":{"total":43,"shown":5,"withheld":38,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Association of psychiatric comorbidity with worse quality of life despite clear or almost clear skin.","year":2026,"journal":"Journal of the European Academy of Dermatology and Venereology : JEADV","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42241019/","status":"verified"},{"title":"Inadequate reporting and citation of diagnostic code validation in dermatology epidemiology studies.","year":2026,"journal":"Journal of the European Academy of Dermatology and Venereology : JEADV","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42312879/","status":"verified"},{"title":"Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA.","year":2026,"journal":"Dermatology and therapy","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41801544/","status":"verified"},{"title":"Combined Low Dose Oral Minoxidil and Immunomodulator Efficacy and Safety in Alopecia Areata: A Systematic Review.","year":2026,"journal":"International journal of dermatology","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41367121/","status":"verified"},{"title":"Improvement in Patient-Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO-2b/3.","year":2026,"journal":"International journal of dermatology","types":["Journal Article","Randomized Controlled Trial","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41069027/","status":"verified"}],"most_cited":{"total":551,"shown":5,"withheld":546,"rows":[{"title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features","year":2008,"cited_by_count":933,"type":"article","source_url":"https://doi.org/10.1016/j.jaad.2007.11.020"},{"title":"Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening","year":2020,"cited_by_count":272,"type":"article","source_url":"https://doi.org/10.1001/jamadermatol.2019.5014"},{"title":"Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis","year":2016,"cited_by_count":191,"type":"article","source_url":"https://doi.org/10.1001/jamadermatol.2016.3816"},{"title":"The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum","year":2018,"cited_by_count":159,"type":"article","source_url":"https://doi.org/10.1001/jamadermatol.2017.5978"},{"title":"Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States","year":2018,"cited_by_count":147,"type":"article","source_url":"https://doi.org/10.1016/j.jid.2018.04.027"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"John S. Barbieri","coauthored_works":55},{"name":"Cara Joyce","coauthored_works":53},{"name":"Priya Manjaly","coauthored_works":35}],"source":"works"},"presence":{"owned_accounts":{"total":5,"shown":3,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/arash-mostaghimi-md","status":"verified"},{"platform":"linkedin","url":"https://www.linkedin.com/in/arash-mostaghimi","status":"verified"},{"platform":"google_scholar","url":"https://scholar.google.com/citations?user=0VaCfdkAAAAJ&hl=en","status":"verified"}]},"mentions":{"total":5,"shown":3,"rows":[{"url":"https://podcasts.apple.com/us/podcast/9-is-a-med-derm-program-right-for-me-should-i-talk/id1586707149?i=1000568415238&uo=4","platform":"apple_podcasts","status":"provisional"},{"url":"https://podcasts.apple.com/us/podcast/an-interview-with-generalized-pustular-psoriasis/id1604615566?i=1000702530925&uo=4","platform":"apple_podcasts","status":"provisional"},{"url":"https://podcasts.apple.com/us/podcast/episode-8-is-this-dress-an-interview-with-dr/id1552571646?i=1000508008016&uo=4","platform":"apple_podcasts","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, MPA, MPH, FAAD","source_url":"https://advancing-derm.org/bio/arash-mostaghimi/","status":"provisional","collected_at":"2026-11-09"},{"value":"Board certifications in dermatology, internal medicine, and clinical informatics","source_url":"https://advancing-derm.org/bio/arash-mostaghimi/","status":"provisional","collected_at":"2026-11-09"}]},"roles":{"total":4,"shown":3,"rows":[{"value":"Director of the Dermatology Inpatient Service, Brigham & Women's Hospital","source_url":"https://advancing-derm.org/bio/arash-mostaghimi/","status":"provisional","collected_at":"2026-11-09"},{"value":"Co-director of the Complex Medical Dermatology Fellowship","source_url":"https://advancing-derm.org/bio/arash-mostaghimi/","status":"provisional","collected_at":"2026-11-09"},{"value":"MDS President-Elect","source_url":"https://meddermsociety.org/recognizing-leaders-shape-future-medical-dermatology/","status":"provisional","collected_at":"2026-11-09"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"Recipient of numerous teaching and mentorship awards","source_url":"https://advancing-derm.org/bio/arash-mostaghimi/","status":"provisional","collected_at":"2026-11-09"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Clinical Advisory Board, Pelagepharma","source_url":"https://pelagepharma.com/team/arash-mostaghimi/","status":"provisional","collected_at":"2026-11-09"},{"value":"Harvard Medical School (Associate Professor of Dermatology)","source_url":"https://advancing-derm.org/bio/arash-mostaghimi/","status":"provisional","collected_at":"2026-11-09"}]},"media":{"total":6,"shown":3,"rows":[{"value":"Guest, Addressing D.R.E.S.S. Podcast (Episode 8, interview)","source_url":"https://podcasts.apple.com/us/podcast/episode-8-is-this-dress-an-interview-with-dr/id1552571646?i=1000508008016&uo=4","status":"provisional","collected_at":"2026-11-09"},{"value":"Guest, The DIGA Podcast (episode #9)","source_url":"https://podcasts.apple.com/us/podcast/9-is-a-med-derm-program-right-for-me-should-i-talk/id1586707149?i=1000568415238&uo=4","status":"provisional","collected_at":"2026-11-09"},{"value":"Guest, SkinSync (Alopecia Areata and the JAK inhibitor Revolution)","source_url":"https://podcasts.apple.com/us/podcast/alopecia-areata-and-the-jak-inhibitor-revolution-with/id1819392092?i=1000778517187&uo=4","status":"provisional","collected_at":"2026-11-09"}]},"public_positions":{"total":1,"shown":1,"rows":[{"value":"Advises pharmaceutical and technology companies on drug development, clinical trials, and AI","source_url":"https://dermatology-conferences.com/speaker/arash-mostaghimi","status":"provisional","collected_at":"2026-11-09"}]}},"similar":[{"name":"Paul Ridker","slug":"paul-ridker","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/paul-ridker","json_url":"https://www.findmykol.com/kol/paul-ridker/profile.json"},{"name":"Scott Solomon","slug":"scott-solomon","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/scott-solomon","json_url":"https://www.findmykol.com/kol/scott-solomon/profile.json"},{"name":"Marc Pfeffer","slug":"marc-pfeffer","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/marc-pfeffer","json_url":"https://www.findmykol.com/kol/marc-pfeffer/profile.json"},{"name":"Reisa Sperling","slug":"reisa-sperling","institution":"Brigham and Women's Hospital","specialty":"Neurology","url":"https://www.findmykol.com/kol/reisa-sperling","json_url":"https://www.findmykol.com/kol/reisa-sperling/profile.json"},{"name":"Bridget Grant","slug":"bridget-grant","institution":"Bassett Medical Center","specialty":"Dermatology","url":"https://www.findmykol.com/kol/bridget-grant","json_url":"https://www.findmykol.com/kol/bridget-grant/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Andrew Blauvelt","slug":"andrew-blauvelt","institution":"University of Maryland School of Medicine","specialty":"Dermatology","url":"https://www.findmykol.com/kol/andrew-blauvelt","json_url":"https://www.findmykol.com/kol/andrew-blauvelt/profile.json"},{"name":"Howard Maibach","slug":"howard-maibach","institution":"University of California, San Francisco","specialty":"Dermatology","url":"https://www.findmykol.com/kol/howard-maibach","json_url":"https://www.findmykol.com/kol/howard-maibach/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":29,"congress":64,"publications":38,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-09"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-09"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"}},"methodology_url":"https://www.findmykol.com/about#methodology"}